Get to know our clinical trials
Trial to evaluate the safety of GEN1042 in subjects with malignant solid tumors.
THE AIM OF THE TRIAL IS TO TEST WHETHER GEN1042 IS USEFUL AGAINST CERTAIN TYPES OF SOLID TUMOR CANCERS.
- FIRST IN-HUMAN, OPEN-LABEL, DOSE-ESCALATION TRIAL WITH EXTENSION COHORTS TO EVALUATE THE SAFETY OF GEN1042 IN SUBJECTS WITH MALIGNANT SOLID TUMORS
- Code EudraCT: 2018-003716-47
- Protocol number: GCT1042-01
- Promoter: Genmab A/S
- Link to Clinical Trials
* The trials only admit a limited number of patients and are subject to inclusion and exclusion criteria. The specialist who assesses your case will inform you of the conditions required to participate in the clinical trial.
Do you want to participate in this trial?
Request an appointment for our specialists to assess whether you qualify for this clinical trial
Do you prefer to send us your reports?
If you prefer, you can send us your medical information and our specialists will evaluate your case without the need to come to the Clinica.